Elypta Is A Swedish Molecular Diagnostics Company Founded In 2017Headquartered In Stockholmthe Company Aims To Reduce Cancer Mortality Through Earlier Detection And Closer Monitoring Of The Diseaseelypta S Team Includes Co Founders Jens Nielsen And Francesco Gattowith Karl Bergman Serving As Ceo Elypta Specializes In A Metabolism Based Liquid Biopsy Platform That Measures Glycosaminoglycan Biomarkersgagomeusing Machine Learning Algorithmsthis Technology Focuses On Early Cancer Detectionmonitoring For Recurrenceand Assessing Treatment Responseselypta S Approach Is Notable For Its Pan Cancer Potential And Cost Efficient Mass Spectrometry Based Assaysthe Company S Products Are Designed For The Healthcare Industrysupporting Clinical Diagnostics In Cancer Careelypta Has Secured Significant Funding For Research And Developmentincluding A A 6 1 Million Investment In 2020And Is Involved In Clinical Trials Aimed At Improving Cancer Detection And Monitoring
No conferences found for this company.
| Company Name | Elypta Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
